Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance. | NCT00938951 | Trialant
CompletedInterventionalNot ApplicableUpdated Feb 9, 2012
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
ClinicalTrials.gov ID
NCT00938951
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
16Actual
Last Update Posted
Feb 9, 2012Estimated
Start Date
Jun 2009
Primary Completion Date
Jul 2009Actual
Brief Summary
The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.
Dry Eye Symptoms
Visual Performance
Systane® Ultra
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Player/ Coach must answer "Yes" to the survey eligibility question.
Player/Coach must voluntarily agree to participate in survey